{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:54:55Z","timestamp":1787961295368,"version":"build-2784847793"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00432-023-04745-8","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T14:04:34Z","timestamp":1682431474000},"page":"8557-8571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Diagnostic performance of RASSF1A and SHOX2 methylation combined with EGFR mutations for differentiation between small pulmonary nodules"],"prefix":"10.1007","volume":"149","author":[{"given":"Xiang-Yu","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"4745_CR1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"DR Aberle","year":"2011","unstructured":"Aberle DR et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395\u2013409. https:\/\/doi.org\/10.1056\/NEJMoa1102873","journal-title":"N Engl J Med"},{"key":"4745_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.suronc.2019.05.009","volume":"30","author":"Y Bao","year":"2019","unstructured":"Bao Y, Liu X, Liu Y, Wang S, Wu B (2019) Ras-association domain family 1 (RASSF1A) gene regulates progression, migration and invasion of bladder cancer. Surg Oncol 30:63\u201371. https:\/\/doi.org\/10.1016\/j.suronc.2019.05.009","journal-title":"Surg Oncol"},{"key":"4745_CR3","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.1158\/1078-0432.Ccr-10-3436","volume":"17","author":"S Begum","year":"2011","unstructured":"Begum S et al (2011) An epigenetic marker panel for detection of lung cancer using cell-free serum DNA. Clin Cancer Res 17:4494\u20134503. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-10-3436","journal-title":"Clin Cancer Res"},{"key":"4745_CR4","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.170070","author":"S Blandin Knight","year":"2017","unstructured":"Blandin Knight S, Crosbie PA, Balata H, Chudziak J, Hussell T, Dive C (2017) Progress and prospects of early detection in lung cancer. Open Biol. https:\/\/doi.org\/10.1098\/rsob.170070","journal-title":"Open Biol"},{"key":"4745_CR5","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.celrep.2014.06.053","volume":"8","author":"D Brocks","year":"2014","unstructured":"Brocks D et al (2014) Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer. Cell Rep 8:798\u2013806. https:\/\/doi.org\/10.1016\/j.celrep.2014.06.053","journal-title":"Cell Rep"},{"key":"4745_CR6","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/ijc.24896","volume":"126","author":"L Buckingham","year":"2010","unstructured":"Buckingham L et al (2010) PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Int J Cancer 126:1630\u20131639. https:\/\/doi.org\/10.1002\/ijc.24896","journal-title":"Int J Cancer"},{"key":"4745_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1479-5876-8-86","volume":"8","author":"M Castro","year":"2010","unstructured":"Castro M et al (2010) Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer. J Transl Med 8:86. https:\/\/doi.org\/10.1186\/1479-5876-8-86","journal-title":"J Transl Med"},{"key":"4745_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.athoracsur.2010.04.062","volume":"90","author":"RJ Cerfolio","year":"2010","unstructured":"Cerfolio RJ et al (2010) The true false negative rates of esophageal and endobronchial ultrasound in the staging of mediastinal lymph nodes in patients with non-small cell lung cancer. Ann Thorac Surg 90:427\u2013434. https:\/\/doi.org\/10.1016\/j.athoracsur.2010.04.062","journal-title":"Ann Thorac Surg"},{"key":"4745_CR9","doi-asserted-by":"publisher","first-page":"5472","DOI":"10.1038\/s41467-019-13460-3","volume":"10","author":"H Chen","year":"2019","unstructured":"Chen H et al (2019) Genomic and immune profiling of pre-invasive lung adenocarcinoma. Nat Commun 10:5472. https:\/\/doi.org\/10.1038\/s41467-019-13460-3","journal-title":"Nat Commun"},{"key":"4745_CR10","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1038\/onc.2015.85","volume":"34","author":"WK Cheung","year":"2015","unstructured":"Cheung WK, Nguyen DX (2015) Lineage factors and differentiation states in lung cancer progression. Oncogene 34:5771\u20135780. https:\/\/doi.org\/10.1038\/onc.2015.85","journal-title":"Oncogene"},{"key":"4745_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00428-011-1079-9","volume":"459","author":"JH Chung","year":"2011","unstructured":"Chung JH, Lee HJ, Kim BH, Cho NY, Kang GH (2011) DNA methylation profile during multistage progression of pulmonary adenocarcinomas. Virchows Arch 459:201\u2013211. https:\/\/doi.org\/10.1007\/s00428-011-1079-9","journal-title":"Virchows Arch"},{"key":"4745_CR12","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/JTO.0b013e31824294de","volume":"7","author":"B Cucuruz","year":"2012","unstructured":"Cucuruz B et al (2012) MAGE qPCR improves the sensitivity and accuracy of EBUS-TBNA for the detection of lymphatic cancer spread. J Thorac Oncol 7:690\u2013697. https:\/\/doi.org\/10.1097\/JTO.0b013e31824294de","journal-title":"J Thorac Oncol"},{"key":"4745_CR13","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/annonc\/mdt365","volume":"24","author":"K Darwiche","year":"2013","unstructured":"Darwiche K et al (2013) Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging. Ann Oncol 24:2866\u20132870. https:\/\/doi.org\/10.1093\/annonc\/mdt365","journal-title":"Ann Oncol"},{"key":"4745_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13048-019-0503-7","volume":"12","author":"V Dochez","year":"2019","unstructured":"Dochez V, Caillon H, Vaucel E, Dimet J, Winer N, Ducarme G (2019) Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review. J Ovarian Res 12:28. https:\/\/doi.org\/10.1186\/s13048-019-0503-7","journal-title":"J Ovarian Res"},{"key":"4745_CR15","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1158\/0008-5472.Can-15-1008","volume":"76","author":"F Dubois","year":"2016","unstructured":"Dubois F et al (2016) RASSF1A suppresses the invasion and metastatic potential of human non-small cell lung cancer cells by inhibiting YAP activation through the GEF-H1\/RhoB pathway. Cancer Res 76:1627\u20131640. https:\/\/doi.org\/10.1158\/0008-5472.Can-15-1008","journal-title":"Cancer Res"},{"key":"4745_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.1024","volume":"196","author":"M Esteller","year":"2002","unstructured":"Esteller M, Herman JG (2002) Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 196:1\u20137. https:\/\/doi.org\/10.1002\/path.1024","journal-title":"J Pathol"},{"key":"4745_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.849024","author":"H Gao","year":"2022","unstructured":"Gao H et al (2022) The diagnostic potential of SHOX2 and RASSF1A DNA methylation in early lung adenocarcinoma. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.849024","journal-title":"Front Oncol"},{"key":"4745_CR18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/bjc.2015.221","volume":"113","author":"AM Grawenda","year":"2015","unstructured":"Grawenda AM, O\u2019Neill E (2015) Clinical utility of RASSF1A methylation in human malignancies. Br J Cancer 113:372\u2013381. https:\/\/doi.org\/10.1038\/bjc.2015.221","journal-title":"Br J Cancer"},{"key":"4745_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.lungcan.2009.11.002","volume":"69","author":"SE Hawes","year":"2010","unstructured":"Hawes SE et al (2010) DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type. Lung Cancer 69:172\u2013179. https:\/\/doi.org\/10.1016\/j.lungcan.2009.11.002","journal-title":"Lung Cancer"},{"key":"4745_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/carcin\/bgs363","volume":"34","author":"G Heller","year":"2013","unstructured":"Heller G et al (2013) Genome-wide CpG island methylation analyses in non-small cell lung cancer patients. Carcinogenesis 34:513\u2013521. https:\/\/doi.org\/10.1093\/carcin\/bgs363","journal-title":"Carcinogenesis"},{"key":"4745_CR21","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1038\/s41467-019-10877-8","volume":"10","author":"X Hu","year":"2019","unstructured":"Hu X et al (2019) Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma. Nat Commun 10:2978. https:\/\/doi.org\/10.1038\/s41467-019-10877-8","journal-title":"Nat Commun"},{"key":"4745_CR22","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41467-021-20907-z","volume":"12","author":"X Hu","year":"2021","unstructured":"Hu X et al (2021) Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas. Nat Commun 12:687. https:\/\/doi.org\/10.1038\/s41467-021-20907-z","journal-title":"Nat Commun"},{"key":"4745_CR23","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1038\/s41467-020-16295-5","volume":"11","author":"X Hua","year":"2020","unstructured":"Hua X et al (2020) Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma. Nat Commun 11:2459. https:\/\/doi.org\/10.1038\/s41467-020-16295-5","journal-title":"Nat Commun"},{"key":"4745_CR24","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1158\/1078-0432.Ccr-16-1371","volume":"23","author":"A Hulbert","year":"2017","unstructured":"Hulbert A et al (2017) Early detection of lung cancer using DNA promoter hypermethylation in plasma and sputum. Clin Cancer Res 23:1998\u20132005. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-16-1371","journal-title":"Clin Cancer Res"},{"key":"4745_CR25","doi-asserted-by":"publisher","first-page":"8258","DOI":"10.1038\/ncomms9258","volume":"6","author":"E Izumchenko","year":"2015","unstructured":"Izumchenko E et al (2015) Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA. Nat Commun 6:8258. https:\/\/doi.org\/10.1038\/ncomms9258","journal-title":"Nat Commun"},{"key":"4745_CR26","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.jtho.2016.04.006","volume":"11","author":"R Kakinuma","year":"2016","unstructured":"Kakinuma R et al (2016) Natural history of pulmonary subsolid nodules: a prospective multicenter study. J Thorac Oncol 11:1012\u20131028. https:\/\/doi.org\/10.1016\/j.jtho.2016.04.006","journal-title":"J Thorac Oncol"},{"key":"4745_CR27","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.tibtech.2018.04.002","volume":"36","author":"ID Karemaker","year":"2018","unstructured":"Karemaker ID, Vermeulen M (2018) Single-cell DNA methylation profiling: technologies and biological applications. Trends Biotechnol 36:952\u2013965. https:\/\/doi.org\/10.1016\/j.tibtech.2018.04.002","journal-title":"Trends Biotechnol"},{"key":"4745_CR28","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1158\/0008-5472.Can-15-3278","volume":"76","author":"M Klutstein","year":"2016","unstructured":"Klutstein M, Nejman D, Greenfield R, Cedar H (2016) DNA methylation in cancer and aging. Cancer Res 76:3446\u20133450. https:\/\/doi.org\/10.1158\/0008-5472.Can-15-3278","journal-title":"Cancer Res"},{"key":"4745_CR29","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1097\/JTO.0b013e318220ef9a","volume":"6","author":"C Kneip","year":"2011","unstructured":"Kneip C et al (2011) SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. J Thorac Oncol 6:1632\u20131638. https:\/\/doi.org\/10.1097\/JTO.0b013e318220ef9a","journal-title":"J Thorac Oncol"},{"key":"4745_CR30","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1158\/1078-0432.Ccr-12-2848","volume":"19","author":"E Ko","year":"2013","unstructured":"Ko E et al (2013) Association of RASSF1A and p63 with poor recurrence-free survival in node-negative stage I-II non-small cell lung cancer. Clin Cancer Res 19:1204\u20131212. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-12-2848","journal-title":"Clin Cancer Res"},{"key":"4745_CR31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/annonc\/mdu505","volume":"26","author":"Y Kobayashi","year":"2015","unstructured":"Kobayashi Y, Mitsudomi T, Sakao Y, Yatabe Y (2015) Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth. Ann Oncol 26:156\u2013161. https:\/\/doi.org\/10.1093\/annonc\/mdu505","journal-title":"Ann Oncol"},{"key":"4745_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s0169-5002(01)00185-4","volume":"33","author":"K Kodama","year":"2001","unstructured":"Kodama K et al (2001) Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer 33:17\u201325. https:\/\/doi.org\/10.1016\/s0169-5002(01)00185-4","journal-title":"Lung Cancer"},{"key":"4745_CR33","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00432-020-03188-9","volume":"146","author":"N Li","year":"2020","unstructured":"Li N, Zeng Y, Huang J (2020) Signaling pathways and clinical application of RASSF1A and SHOX2 in lung cancer. J Cancer Res Clin Oncol 146:1379\u20131393. https:\/\/doi.org\/10.1007\/s00432-020-03188-9","journal-title":"J Cancer Res Clin Oncol"},{"key":"4745_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.688274","author":"N Li","year":"2021","unstructured":"Li N et al (2021) Analysis of the prognostic value and gene expression mechanism of SHOX2 in lung adenocarcinoma. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2021.688274","journal-title":"Front Mol Biosci"},{"key":"4745_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1471-2407-7-74","volume":"7","author":"Y Liu","year":"2007","unstructured":"Liu Y, Gao W, Siegfried JM, Weissfeld JL, Luketich JD, Keohavong P (2007) Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers. BMC Cancer 7:74. https:\/\/doi.org\/10.1186\/1471-2407-7-74","journal-title":"BMC Cancer"},{"key":"4745_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.trsl.2017.05.008","volume":"189","author":"J Mari-Alexandre","year":"2017","unstructured":"Mari-Alexandre J et al (2017) Translating cancer epigenomics into the clinic: focus on lung cancer. Transl Res 189:76\u201392. https:\/\/doi.org\/10.1016\/j.trsl.2017.05.008","journal-title":"Transl Res"},{"key":"4745_CR37","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1378\/chest.11-3306","volume":"143","author":"H Matsuguma","year":"2013","unstructured":"Matsuguma H et al (2013) Characteristics of subsolid pulmonary nodules showing growth during follow-up with CT scanning. Chest 143:436\u2013443. https:\/\/doi.org\/10.1378\/chest.11-3306","journal-title":"Chest"},{"key":"4745_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ccell.2015.07.012","volume":"28","author":"T Mazor","year":"2015","unstructured":"Mazor T et al (2015) DNA methylation and somatic mutations converge on the cell cycle and define similar evolutionary histories in brain tumors. Cancer Cell 28:307\u2013317. https:\/\/doi.org\/10.1016\/j.ccell.2015.07.012","journal-title":"Cancer Cell"},{"key":"4745_CR39","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3346\/jkms.2003.18.4.494","volume":"18","author":"NH Myong","year":"2003","unstructured":"Myong NH (2003) Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins. J Korean Med Sci 18:494\u2013500. https:\/\/doi.org\/10.3346\/jkms.2003.18.4.494","journal-title":"J Korean Med Sci"},{"key":"4745_CR40","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.prp.2019.01.032","volume":"215","author":"QN Nguyen","year":"2019","unstructured":"Nguyen QN et al (2019) 1-Genetic and epigenetic alterations of the EGFR and mutually independent association with BRCA1, MGMT, and RASSF1A methylations in Vietnamese lung adenocarcinomas. Pathol Res Pract 215:885\u2013892. https:\/\/doi.org\/10.1016\/j.prp.2019.01.032","journal-title":"Pathol Res Pract"},{"key":"4745_CR41","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.jtho.2019.02.029","volume":"14","author":"RU Osarogiagbon","year":"2019","unstructured":"Osarogiagbon RU et al (2019) Early-stage NSCLC: advances in thoracic oncology 2018. J Thorac Oncol 14:968\u2013978. https:\/\/doi.org\/10.1016\/j.jtho.2019.02.029","journal-title":"J Thorac Oncol"},{"key":"4745_CR42","doi-asserted-by":"publisher","first-page":"13306","DOI":"10.1073\/pnas.0405220101","volume":"101","author":"W Pao","year":"2004","unstructured":"Pao W et al (2004) EGF receptor gene mutations are common in lung cancers from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A 101:13306\u201313311. https:\/\/doi.org\/10.1073\/pnas.0405220101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4745_CR43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1001\/jamainternmed.2013.12738","volume":"174","author":"EF Patz","year":"2014","unstructured":"Patz EF et al (2014) Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 174:269\u2013274. https:\/\/doi.org\/10.1001\/jamainternmed.2013.12738","journal-title":"JAMA Intern Med"},{"key":"4745_CR44","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1128\/mcb.01506-13","volume":"34","author":"RR Ram","year":"2014","unstructured":"Ram RR, Mendiratta S, Bodemann BO, Torres MJ, Eskiocak U, White MA (2014) RASSF1A inactivation unleashes a tumor suppressor\/oncogene cascade with context-dependent consequences on cell cycle progression. Mol Cell Biol 34:2350\u20132358. https:\/\/doi.org\/10.1128\/mcb.01506-13","journal-title":"Mol Cell Biol"},{"key":"4745_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1148\/radiol.2221001154","volume":"222","author":"M Remy-Jardin","year":"2002","unstructured":"Remy-Jardin M, Edme JL, Boulenguez C, Remy J, Mastora I, Sobaszek A (2002) Longitudinal follow-up study of smoker\u2019s lung with thin-section CT in correlation with pulmonary function tests. Radiology 222:261\u2013270. https:\/\/doi.org\/10.1148\/radiol.2221001154","journal-title":"Radiology"},{"key":"4745_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.anndiagpath.2017.01.007","volume":"27","author":"M Ren","year":"2017","unstructured":"Ren M, Wang C, Sheng D, Shi Y, Jin M, Xu S (2017) Methylation analysis of SHOX2 and RASSF1A in bronchoalveolar lavage fluid for early lung cancer diagnosis. Ann Diagn Pathol 27:57\u201361. https:\/\/doi.org\/10.1016\/j.anndiagpath.2017.01.007","journal-title":"Ann Diagn Pathol"},{"key":"4745_CR47","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.trecan.2019.12.006","volume":"6","author":"D Roy","year":"2020","unstructured":"Roy D, Tiirikainen M (2020) Diagnostic power of DNA methylation classifiers for early detection of cancer. Trends Cancer 6:78\u201381. https:\/\/doi.org\/10.1016\/j.trecan.2019.12.006","journal-title":"Trends Cancer"},{"key":"4745_CR48","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1586\/erm.13.37","volume":"13","author":"J Sandoval","year":"2013","unstructured":"Sandoval J, Peir\u00f3-Chova L, Pallard\u00f3 FV, Garc\u00eda-Gim\u00e9nez JL (2013) Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities. Expert Rev Mol Diagn 13:457\u2013471. https:\/\/doi.org\/10.1586\/erm.13.37","journal-title":"Expert Rev Mol Diagn"},{"key":"4745_CR49","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1186\/1471-2407-10-600","volume":"10","author":"B Schmidt","year":"2010","unstructured":"Schmidt B et al (2010) SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer 10:600. https:\/\/doi.org\/10.1186\/1471-2407-10-600","journal-title":"BMC Cancer"},{"key":"4745_CR50","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1158\/0008-5472.Can-17-2466","volume":"78","author":"ML Schmidt","year":"2018","unstructured":"Schmidt ML, Hobbing KR, Donninger H, Clark GJ (2018) RASSF1A deficiency enhances RAS-driven lung tumorigenesis. Cancer Res 78:2614\u20132623. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-2466","journal-title":"Cancer Res"},{"key":"4745_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021443","author":"SA Selamat","year":"2011","unstructured":"Selamat SA et al (2011) DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0021443","journal-title":"PLoS ONE"},{"key":"4745_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.565780","author":"J Shi","year":"2020","unstructured":"Shi J et al (2020) Performance evaluation of SHOX2 and RASSF1A methylation for the aid in diagnosis of lung cancer based on the analysis of FFPE specimen. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.565780","journal-title":"Front Oncol"},{"key":"4745_CR53","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/jnci\/dji055","volume":"97","author":"H Shigematsu","year":"2005","unstructured":"Shigematsu H et al (2005) Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97:339\u2013346. https:\/\/doi.org\/10.1093\/jnci\/dji055","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 8","key":"4745_CR54","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1289\/ehp.95103s8131","volume":"103","author":"DR Shopland","year":"1995","unstructured":"Shopland DR (1995) Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking. Environ Health Perspect 103(Suppl 8):131\u2013142. https:\/\/doi.org\/10.1289\/ehp.95103s8131","journal-title":"Environ Health Perspect"},{"key":"4745_CR55","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21442","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.21442","journal-title":"CA Cancer J Clin"},{"key":"4745_CR56","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"4745_CR57","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/s0003-4975(02)03895-x","volume":"74","author":"K Suzuki","year":"2002","unstructured":"Suzuki K, Asamura H, Kusumoto M, Kondo H, Tsuchiya R (2002) \u201cEarly\u201d peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg 74:1635\u20131639. https:\/\/doi.org\/10.1016\/s0003-4975(02)03895-x","journal-title":"Ann Thorac Surg"},{"key":"4745_CR58","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/ijc.10787","volume":"103","author":"S Toyooka","year":"2003","unstructured":"Toyooka S et al (2003) Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer 103:153\u2013160. https:\/\/doi.org\/10.1002\/ijc.10787","journal-title":"Int J Cancer"},{"key":"4745_CR59","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1158\/0008-5472.CAN-05-2625","volume":"66","author":"S Toyooka","year":"2006","unstructured":"Toyooka S et al (2006) Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers. Cancer Res 66:1371\u20131375. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-2625","journal-title":"Cancer Res"},{"key":"4745_CR60","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1056\/NEJMoa050736","volume":"353","author":"MS Tsao","year":"2005","unstructured":"Tsao MS et al (2005) Erlotinib in lung cancer: molecular and clinical predictors of outcome. N Engl J Med 353:133\u2013144. https:\/\/doi.org\/10.1056\/NEJMoa050736","journal-title":"N Engl J Med"},{"key":"4745_CR61","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1158\/0008-5472.Can-08-2489","volume":"69","author":"T Vaissi\u00e8re","year":"2009","unstructured":"Vaissi\u00e8re T et al (2009) Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res 69:243\u2013252. https:\/\/doi.org\/10.1158\/0008-5472.Can-08-2489","journal-title":"Cancer Res"},{"key":"4745_CR62","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/carcin\/bgv146","volume":"36","author":"M Vizoso","year":"2015","unstructured":"Vizoso M et al (2015) Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts. Carcinogenesis 36:1453\u20131463. https:\/\/doi.org\/10.1093\/carcin\/bgv146","journal-title":"Carcinogenesis"},{"key":"4745_CR63","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.crad.2018.01.017","volume":"73","author":"XW Wang","year":"2018","unstructured":"Wang XW et al (2018) CT features differentiating pre- and minimally invasive from invasive adenocarcinoma appearing as mixed ground-glass nodules: mass is a potential imaging biomarker. Clin Radiol 73:549\u2013554. https:\/\/doi.org\/10.1016\/j.crad.2018.01.017","journal-title":"Clin Radiol"},{"key":"4745_CR64","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3779\/j.issn.1009-3419.2015.07.09","volume":"18","author":"H Wei","year":"2015","unstructured":"Wei H, Fang N, Guo L, Wu Z, Zhou Q (2015) Meta-analysis of the association between RASSF1A gene promoter methylation and non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 18:443\u2013450. https:\/\/doi.org\/10.3779\/j.issn.1009-3419.2015.07.09","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"4745_CR65","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jtho.2016.08.123","volume":"12","author":"G Weiss","year":"2017","unstructured":"Weiss G, Schlegel A, Kottwitz D, K\u00f6nig T, Tetzner R (2017) Validation of the SHOX2\/PTGER4 DNA methylation marker panel for plasma-based discrimination between patients with malignant and nonmalignant lung disease. J Thorac Oncol 12:77\u201384. https:\/\/doi.org\/10.1016\/j.jtho.2016.08.123","journal-title":"J Thorac Oncol"},{"key":"4745_CR66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.lungcan.2011.05.021","volume":"74","author":"Y Yatabe","year":"2011","unstructured":"Yatabe Y, Borczuk AC, Powell CA (2011) Do all lung adenocarcinomas follow a stepwise progression? Lung Cancer 74:7\u201311. https:\/\/doi.org\/10.1016\/j.lungcan.2011.05.021","journal-title":"Lung Cancer"},{"key":"4745_CR67","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.7150\/jca.21368","volume":"8","author":"C Zhang","year":"2017","unstructured":"Zhang C et al (2017) DNA methylation analysis of the SHOX2 and RASSF1A panel in bronchoalveolar lavage fluid for lung cancer diagnosis. J Cancer 8:3585\u20133591. https:\/\/doi.org\/10.7150\/jca.21368","journal-title":"J Cancer"},{"key":"4745_CR68","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.jtho.2019.07.031","volume":"14","author":"C Zhang","year":"2019","unstructured":"Zhang C et al (2019) Genomic landscape and immune microenvironment features of preinvasive and early invasive lung adenocarcinoma. J Thorac Oncol 14:1912\u20131923. https:\/\/doi.org\/10.1016\/j.jtho.2019.07.031","journal-title":"J Thorac Oncol"},{"key":"4745_CR69","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.2147\/ott.S94300","volume":"8","author":"QT Zhao","year":"2015","unstructured":"Zhao QT et al (2015) Diagnostic value of SHOX2 DNA methylation in lung cancer: a meta-analysis. Onco Targets Ther 8:3433\u20133439. https:\/\/doi.org\/10.2147\/ott.S94300","journal-title":"Onco Targets Ther"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04745-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-04745-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04745-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T20:45:39Z","timestamp":1690490739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-04745-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["4745"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-04745-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"25 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No grants or conflicts of interest supported this effort.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}